Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dédée F Murrell

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Dermatologic Clinics|May 8, 2010
Epidermolysis bullosa in Australia and New ZealandDédée F Murrell
Experimental Dermatology|June 19, 2008
Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosaNingning Dang, Dédée F Murrell
Expert Opinion on Pharmacotherapy|August 19, 2024
The potential of Bruton's tyrosine kinase (BTK) inhibitors in the pharmacotherapeutic management of immune and dermatological diseaseHenry Tseng, Dédée F Murrell
Dermatologic Clinics|May 25, 2011
Objective scoring systems for disease activity in autoimmune bullous diseaseDeshan F Sebaratnam, Dédée F Murrell
Dermatologic Clinics|May 8, 2010
Fibroblast-based cell therapy strategy for recessive dystrophic epidermolysis bullosaW F Yan, Dédée F Murrell
International Journal of Women'S Dermatology|June 1, 2017
Lupus profundus limited to a site of trauma: Case report and review of the literatureMaría Adriana Castrillón, Dédée F Murrell
Clinics in Dermatology|September 14, 2021
Managing epidermolysis bullosa during the coronavirus pandemic: Experience and idealsMae Ramirez-Quizon, Dédée F Murrell
International Journal of Women'S Dermatology|May 12, 2017
A systematic review of patients with Merkel cell carcinoma of the head and neck and a negative sentinel lymph node biopsyNigel G Maher, Dédée F Murrell
Dermatologic Clinics|May 25, 2011
Diagnosis and clinical features of pemphigus vulgarisSupriya S Venugopal, Dédée F Murrell
Dermatologic Clinics|May 25, 2011
Pemphigus and quality of lifeShien-Ning Chee, Dédée F Murrell
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Dermatologic Clinics|May 8, 2010
Epidermolysis bullosa in Australia and New ZealandDédée F Murrell
Experimental Dermatology|June 19, 2008
Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosaNingning Dang, Dédée F Murrell
Expert Opinion on Pharmacotherapy|August 19, 2024
The potential of Bruton's tyrosine kinase (BTK) inhibitors in the pharmacotherapeutic management of immune and dermatological diseaseHenry Tseng, Dédée F Murrell
Dermatologic Clinics|May 25, 2011
Objective scoring systems for disease activity in autoimmune bullous diseaseDeshan F Sebaratnam, Dédée F Murrell
Dermatologic Clinics|May 8, 2010
Fibroblast-based cell therapy strategy for recessive dystrophic epidermolysis bullosaW F Yan, Dédée F Murrell
International Journal of Women'S Dermatology|June 1, 2017
Lupus profundus limited to a site of trauma: Case report and review of the literatureMaría Adriana Castrillón, Dédée F Murrell
Clinics in Dermatology|September 14, 2021
Managing epidermolysis bullosa during the coronavirus pandemic: Experience and idealsMae Ramirez-Quizon, Dédée F Murrell
International Journal of Women'S Dermatology|May 12, 2017
A systematic review of patients with Merkel cell carcinoma of the head and neck and a negative sentinel lymph node biopsyNigel G Maher, Dédée F Murrell
Dermatologic Clinics|May 25, 2011
Diagnosis and clinical features of pemphigus vulgarisSupriya S Venugopal, Dédée F Murrell
Dermatologic Clinics|May 25, 2011
Pemphigus and quality of lifeShien-Ning Chee, Dédée F Murrell
Pageof 10